Home > Healthcare > Pharmaceuticals > Vaccines > Ebola Virus Vaccine Market
Ebola Virus Vaccine Market Size
- Report ID: GMI6083
- Published Date: Jun 2023
- Report Format: PDF
Ebola Virus Vaccine Market Size
Ebola Virus Vaccine Market size accounted for USD 4.4 million in 2022 and is estimated to grow at 32.6% to reach USD 71 million by 2032. The growing incidence of zoonotic diseases across the globe will drive the market expansion.
For instance, in 2020, according to the World Health Organization (WHO), around 60% of known infectious diseases and over 75% of emerging infectious diseases are zoonotic in origin. Thus, increasing incidence of zoonotic disease such as Ebola and zoonotic influenza among others is expected to boost the market progression. Furthermore, increasing public health initiatives to prevent and control Ebola outbreaks have resulted in increased investments in vaccine development and procurement, thereby fostering the market trends.
Ebola virus vaccines are developed using various approaches, such as viral vectors, recombinant proteins and DNA-based platforms. These vaccines typically contain components of the Ebola virus such as viral proteins or genetic material that are modified or attenuated to be safe for use in humans. When administered, the vaccine triggers an immune response that produces specific antibodies and cellular immunity, providing protection against the Ebola virus.
| Report Attribute | Details |
|---|---|
| Base Year: | 2022 |
| Ebola Virus Vaccine Market Size in 2022: | USD 4.4 Million |
| Forecast Period: | 2022 |
| Forecast Period 2022 CAGR: | 32.6% |
| 2022 Value Projection: | USD 71 Million |
| Historical Data for: | 2018 to 2022 |
| No. of Pages: | 70 |
| Tables, Charts & Figures: | 91 |
| Segments covered: | Strain Type, End-use, and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Frequently Asked Questions (FAQ) :
Ebola Virus Vaccine Market Scope
